Page last updated: 2024-08-21

isoxazoles and Epstein-Barr Virus Infections

isoxazoles has been researched along with Epstein-Barr Virus Infections in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barlow, EA; Bilger, A; Bristol, JA; Delecluse, HJ; Kenney, SC; Li, Z; Ma, S; Nawandar, D; Plowshay, J; Romero-Masters, JC; Tsai, MH1
Miyamoto, A; Okamoto, T; Oki, J; Shirai, M; Sugai, R1

Other Studies

2 other study(ies) available for isoxazoles and Epstein-Barr Virus Infections

ArticleYear
Leflunomide/teriflunomide inhibit Epstein-Barr virus (EBV)- induced lymphoproliferative disease and lytic viral replication.
    Oncotarget, 2017, Jul-04, Volume: 8, Issue:27

    Topics: Animals; Apoptosis; B-Lymphocytes; Cell Line, Transformed; Cell Proliferation; Crotonates; Cyclin E; Disease Models, Animal; Epstein-Barr Virus Infections; Gene Expression Regulation; Gene Expression Regulation, Viral; Genes, myc; Herpesvirus 4, Human; Humans; Hydroxybutyrates; Isoxazoles; Leflunomide; Lymphoproliferative Disorders; Mice; NF-kappa B; Nitriles; Toluidines; Virus Activation; Virus Latency; Virus Replication; Xenograft Model Antitumor Assays

2017
Urine stone formation during treatment with zonisamide.
    Brain & development, 2000, Volume: 22, Issue:7

    Topics: Anticonvulsants; Child; Encephalitis, Viral; Epstein-Barr Virus Infections; Female; Hematuria; Herpesvirus 4, Human; Humans; Isoxazoles; Pyuria; Seizures; Urinary Calculi; Zonisamide

2000